Gastric Adenocarcinoma Mimicking Plasmacytoma During the Course of Multiple Myeloma MM in a Geriatric Patient
Öz
Multiple myeloma is the neoplastic proliferation of monoclonal plasma cells, usually bone marrow originated. It may cause various organ dysfunctions. It is not so rare to detect secondary malignancies associated with MM but this co-existence between MM and gastric cancer has been not very frequently reported. Secondary malignancy risk should be kept in mind during the follow-up of patients with MM
Anahtar Kelimeler
Kaynakça
- Sirohi B, Powles R. Multiple Myeloma. Lancet, 2004; 363: 875-87.
- Smith A, Wisloff F, Samson D, UK Myeloma Forum, Nordic Myeloma Study Group, British Committee for Standards in Haematology. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol, 2006; 132: 410-51.
- Dong C, Hemminki K. Second primary neoplasms among 53159 haematolymphoproliferative malignancy patients in Sweden, 1958– 1996: a search for common mechanisms. British Journal of Cancer 2001; 85: 997-1005.
- Demir C, Atmaca M, Tasdemir E, Efe S. Association of multiple myeloma and gastric adenocarcinoma. Journal of Clinical and Experimental Investigations 2011; 2: 110-3.
- Razavi P, Rand KA, Cozen W, Chanan-Khan A, Usmani S, Ailawadhi S. Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics. Blood Cancer Journal, 2013; 3: e121.
- Kyle RA. Long-term survival in multiple myeloma. N Engl J Med, 1983; 308: 314-6.
- Spedini P, Marchetti G, Morandi S. Gastric localization of multiple myeloma. Haematologica, 2001; 86: 223.
- Grudeva-Popova J, Nenova I, Spasova M, Yaneva M, Beleva E, Аnanoshtev N. Multiple myeloma in association with second malignancy. JBUON 2013; 18: 448-52.
- Cui Y, Liu T, Zhou Y, Ji Y, Hou Y, Jin W, et al. Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy. Cancer Res Treat, 2012; 44: 63-8.
Yıl 2016,
Sayı: 3, 178 - 181, 01.09.2016
Öz
Multiple myeloma genellikle kemik iliği kökenli monoklonal plazma hücrelerinin neoplastik proliferasyonudur. Birçok organda fonksiyon bozukluklarına yol açabilir. Multiple myelomlu hastalarda ikincil kanserler nadir olmamakla birlikte mide kanseri ve multiple myelom birlikteliğine literatürde az rastlanılmaktadır. İkincil kanser riski multiple myelomlu hastaların izleminde akılda tutulmalıdır
Anahtar Kelimeler
Kaynakça
- Sirohi B, Powles R. Multiple Myeloma. Lancet, 2004; 363: 875-87.
- Smith A, Wisloff F, Samson D, UK Myeloma Forum, Nordic Myeloma Study Group, British Committee for Standards in Haematology. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol, 2006; 132: 410-51.
- Dong C, Hemminki K. Second primary neoplasms among 53159 haematolymphoproliferative malignancy patients in Sweden, 1958– 1996: a search for common mechanisms. British Journal of Cancer 2001; 85: 997-1005.
- Demir C, Atmaca M, Tasdemir E, Efe S. Association of multiple myeloma and gastric adenocarcinoma. Journal of Clinical and Experimental Investigations 2011; 2: 110-3.
- Razavi P, Rand KA, Cozen W, Chanan-Khan A, Usmani S, Ailawadhi S. Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics. Blood Cancer Journal, 2013; 3: e121.
- Kyle RA. Long-term survival in multiple myeloma. N Engl J Med, 1983; 308: 314-6.
- Spedini P, Marchetti G, Morandi S. Gastric localization of multiple myeloma. Haematologica, 2001; 86: 223.
- Grudeva-Popova J, Nenova I, Spasova M, Yaneva M, Beleva E, Аnanoshtev N. Multiple myeloma in association with second malignancy. JBUON 2013; 18: 448-52.
- Cui Y, Liu T, Zhou Y, Ji Y, Hou Y, Jin W, et al. Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy. Cancer Res Treat, 2012; 44: 63-8.
Toplam 9 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Case Report |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Eylül 2016 |
| Yayımlandığı Sayı | Yıl 2016Sayı: 3 |